share_log

HC Wainwright & Co. Maintains Buy on ITeos Therapeutics, Lowers Price Target to $44

Benzinga ·  Aug 9, 2023 06:23

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains ITeos Therapeutics (NASDAQ:ITOS) with a Buy and lowers the price target from $54 to $44.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment